Progyny, a leading fertility benefits provider, saw steady utilization rates but a surprising slowdown in treatment pace during Q3 2024, raising questions about the future of fertility benefit usage. While revenue and client numbers remain strong, declining profits and the emergence of competitors offering less comprehensive plans present challenges. Tune in to explore how Progyny is navigating this evolving landscape and what it means for the future of family-building.